Novo Retatru & Dural: A Joint Treatment Approach? Innovative research show a possible combination between Novo Retat, a unique dual agonist for GLP-1R, and Dural, a hyaluronate substance infusion. While Retat addresses glucose dysregulation and body control, Dural offers articulation lu